Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining -1.04% today. In the last week its performance is 0.73%, and 7.37% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 167.06, so today’s gain of -1.04% is a significant step towards its target price. The GAP today is therefore 0.40%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 29212.24, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 98.30%.

At the current price of 130.36, it has a dividend yield of *TBA, and its target price is 167.06. This is with a profit margin of 3.20%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 330.03, as well as a forward P/E of 22.04.

With a current EPS of 0.4, and a forecasted EPS growth for next year at 27.36%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 18.28%.

Performance for the year is -18.14%. Since its IPO date on 2/28/1996, the total performance to date is -31.66%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 1207900, while its average volume is 1752.5. Whilst the total gain today was -1.04%, it did have a day high of -5.81%.

Volatility for this week has been at 2.86%, and 2.97% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 17.91%, while the 52-week-high has reached -32.61%.

Looking at its return of investments, which is 1.60%, and its return on assets is 0.70%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 21.70%. With a sales growth of 18.40% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.39, and has a current ratio of 3.6 and 3.1 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 18.05, and the P/S is 10.35, along with a P/B of 3.56. Meanwhile it has a p/cash of 24.75.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment